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Abstract
Background: In this study we investigated the in vitro and in vivo anticancer effect of carnosol, a naturally occurring
polyphenol, in triple negative breast cancer.
Results: We found that carnosol significantly inhibited the viability and colony growth induced G2 arrest in the triple
negative MDA-MB-231. Blockade of the cell cycle was associated with increased p21/WAF1 expression and downregulation
of p27. Interestingly, carnosol was found to induce beclin1-independent autophagy and apoptosis in MDA-MB-231 cells.
The coexistence of both events, autophagy and apoptosis, was confirmed by electron micrography. Induction of autophagy
was found to be an early event, detected within 3 h post-treatment, which subsequently led to apoptosis. Carnosol
treatment also caused a dose-dependent increase in the levels of phosphorylated extracellular signal-regulated kinase 1 and
2 (pERK1/2). Moreover, we show that carnosol induced DNA damage, reduced the mitochondrial potential and triggered the
activation of the intrinsic and extrinsic apoptotic pathway. Furthermore, we found that carnosol induced a dose-dependent
generation of reactive oxygen species (ROS) and inhibition of ROS by tiron, a ROS scavenger, blocked the induction of
autophagy and apoptosis and attenuated DNA damage. To our knowledge, this is the first report to identify the induction of
autophagy by carnosol.
Conclusion: In conclusion our findings provide strong evidence that carnosol may be an alternative therapeutic candidate
against the aggressive form of breast cancer and hence deserves more exploration.
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Introduction
Breast cancer continues to be the second leading cause of
cancer-related deaths in women. The American Cancer Society
estimated nearly 232,670 new cases and about 40 000 deaths
estimated due to breast cancer in women for the year 2014 [1].
An approximate of 10 to 15% of breast cancer cases belong to
the TNBC (Triple-negative breast cancer) group of cancer. TNBC
lack expression of estrogen, progesterone, and the HER-2
epidermal growth factor membrane receptors, are highly aggres-
sive and invasive with poor prognosis of patients and, do not
respond to hormonal therapies. Currently, there is no defined
standard treatment strategy for prevention of reoccurrence for this
disease other than traditional chemotherapy [2].
Apoptosis, major form of programmed cell death, is believed to
be a defense mechanism and a tumor suppressor pathway essential
for development and maintaining cellular homeostasis. When
deregulated apoptosis leads to uncontrolled proliferation of
damaged cells and a key role in the pathogenesis and progression
of cancer by allowing tumor cells to survive beyond a normal
lifespan, but also leads to resistance to chemo or radiotherapy [3].
Apoptosis can be triggered by diverse cellular signals. These
include intracellular signals produced in response to cellular
stresses, such as increased intracellular Ca2+ concentration, DNA
damage and high levels of reactive oxygen species (ROS). Extrinsic
inducers of apoptosis include bacterial pathogens, toxins, nitric
oxide, growth factors, and hormones [4]. Apoptosis is regulated in
an orderly way by a series of signaling cascades and occurs by two
connected pathways. The extrinsic pathway is initiated by cell
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surface death receptor stimulation and activation of caspase-8,
while the intrinsic pathway involves cytochrome c release from
mitochondria and subsequent caspase-9 activation. Activated
caspase-8 and-9 activate executioner caspases, including caspase-
3, which in turn activate a cytoplasmic endonucleases and
proteases that degrade nuclear materials and nuclear and
cytoskeletal proteins respectively resulting by eliminating abnor-
mal cells [5]. Evasion from apoptosis is a hallmark of cancer cells
which leads to uncontrolled proliferation of damaged cells and
contributes to cancer development and enhances resistance to
conventional anti-cancer therapies, such as radiation and cytotoxic
agents. Most chemotherapeutic agents induce cancer cell death by
activation of the apoptotic pathway. However, most of the
currently used chemotherapeutics drugs are associated with
cytotoxic side-effects and development of chemoresistance [6–7].
Although apoptosis is a common mechanism for most of
chemotherapeutic drugs that induce cancer cell death, recently,
the status of autophagy in cancer therapy has also been given
increasing attention. Autophagy is a highly conserved lysosomal
degradation pathway by which misfolded or aggregated proteins,
damaged organelles and intracellular pathogens are eliminated
[8]. Autophagy starts when such unnecessary byproducts and
damaged organelles are engulfed into double-membrane vesicles
(autophagosomes) and transported to lysosomes where autophago-
somes fuse with lysosomes to form single-membrane autolyso-
somes where the inner engulfed materials are ultimately degraded
and recycled. Therefore, autophagy is essential for maintaining
homeostasis and seems to play a pro-survival role as well [9].
Apoptosis and autophagy are considered two different events;
cross-talk between autophagy and apoptosis exists and the intricate
interplay between these two mechanisms is a big challenge for
cancer treatment. Autophagy seems to play a role in cancer cell
survival and cell death. It contributes to cytoprotective events that
help cancer cells to survive and to protect cells from apoptosis [10].
In other circumstances, autophagy can stimulate a pro-death
signal pathway in cancer cells. Moreover, under some situations,
apoptosis and autophagy can exert synergetic effects, whereas in
other conditions autophagy can be triggered only when apoptosis
is suppressed [10].
Phytochemicals are natural plant-derived compounds that have
been shown to influence in many ways human health. Recently,
these natural compounds gained increasing interest for their health
promoting properties especially with regard to breast cancer
treatment and prevention [11]. Identification and development of
new chemotherapeutic agents from plants have gained significant
recognition in the field of cancer therapy and become a major area
of experimental cancer research. Various phytochemicals present
in the diet were found to (i) kill breast cancer cells in vitro and (ii)
prevent and/or suppress breast cancer progression in various
preclinical animal models [12]. Phytochemicals have been shown
to target breast cancer development and progression through
inhibiting cellular proliferation, suppressing inflammatory process-
es, arresting cell cycle, inducing apoptosis, modulating gene
expression, and inhibiting angiogenesis and invasion potential of
many metastatic cancer cell lines. Phytochemical are becoming
more attractive for cancer prevention and treatment because they
were proven to be very effective, and do not have large side-effect
compared to synthetic drugs. Examples of anticancer drugs
derived from plants and currently in clinical use include the vinca
alkaloids vinblastine and vincristine were isolated from Catharan
roseus, the terpene paclitaxel from Taxus brevifolia Nutt, and the
DNA topoisomerase I inhibitor camptothecin from Camptotheca
acuminata [13]. Hence, screening for new natural phytochemicals
present a major avenue for the discovery of new and more potent
chemopreventive and chemotherapeutic anticancer drugs. Now-
adays, much attention is given in understanding the molecular
mechanism(s) through which these chemotherapeutic phytochem-
icals exerts their anti-cancer effects.
Carnosol is a naturally occurring polyphenol (dietary diterpene)
found in culinary herbs such as rosemary, sage, and oregano.
Studies revealed that carnosol possesses many pharmacological
activities, including anti-inflammatory, anti-oxidant, anti-microbi-
al, and anti-cancer properties [14]. Carnosol has been shown to
have significant growth inhibitory and cytotoxic effects in several
human cancer cell lines and animal models [14]. In fact, carnosol
was shown to inhibit the growth of the HT-1080 human
fibrosarcoma cells [15], MCF-7 human breast cancer cells [16],
PC3 human prostate cancer cells [17] and very recently in human
colon cancer cells [18]. Studies reported that carnosol can interfere
with multiple signaling pathways that are deregulated in inflam-
mation and cancer [14]. As matter of fact, it has been shown that
carnosol inhibited the proliferation, induced G2 arrest and
apoptosis in prostate cancer PC3 cells, by activating the intrinsic
apoptotic pathway [17]. Moreover, carnosol was found to exert its
effect in PC3 cells by affecting several signaling pathways including
inhibition of the PI3K/Akt, and activation of the 5’-adenosine
monophosphate-activated protein kinase (AMPK) pathway [17].
Carnosol also induced intrinsic mitochondrial apoptotic pathway,
through modulating the anti-apoptotic members of the Bcl-2
family of proteins, in acute leukemic cell lines [18].
Additionally, carnosol has been shown to be a potent inhibitor
of angiogenesis both in vitro and in vivo demonstrated by its
ability to inhibit differentiation, proliferation, migration and
proteolytic potential of endothelial cells [19]. Safety wise, carnosol
shown to be safe and well tolerated when administered to animals
and most importantly has a selective toxicity toward cancerous
cells versus non-tumorigenic cells [16].
In the present study, we investigated the effect of carnosol on
the highly proliferative and invasive triple-negative MDA-MB-231
human breast cancer cells. We show that carnosol blocked cell
cycle at G2 phase and induced ROS-dependent apoptosis and
beciln1-independent autophagy in breast cancer cells. We also
show that carnosol inactivated the Signal Transducer and
Activator of Transcription 3 (STAT3) signaling pathway and
efficiently inhibited tumor growth and metastasis in vivo of breast
cancer cells.
Materials and Methods
Cell culture, chemicals and antibodies
Human breast cancer cells MDA-MB-231 were maintained in
Dulbecco Minimal Essential Medium (DMEM) (Hyclone, Cram-
lington, UK). All media were complemented with 10% fetal
bovine serum (FBS) (Hyclone, Cramlington, UK), 100 U/ml
penicillin/streptomycin (Hyclone, Cramlington, UK). Carnosol,
29,79–dichlorofluorescein diacetate (DCFDA) and tiron were
obtained from Sigma Aldrich. Antibodies to p62/SQSTMI were
obtained from Abcam (Abcam, Cambridge, UK). Antibodies to
LC3, cleaved caspase 3, caspase 8, Bax, Bcl2, p27, and pErk1/
2(Th202/Th204), were obtained from Cell Signaling. Antibodies
to caspase 9, cH2AX, p21 (WAFA/Cip1), (ser10) histone H3,
acetyl histone H3, acetyl histone H4 were obtained from Millipore
(Millipore, Hayward, CA, USA). Antibodies to b-actin, pSTAT3
were obtained from Santa Cruz Biotechnology, Inc. Anti-Poly
(ADP-ribose) polymerase (PARP) antibody was obtained from BD
Pharmingen. Beclin-1 siRNA was purchased from Cell Signaling.
Induction of Autophagy and Apoptosis by Carnosol
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Measurement of cellular viability
Cells were seeded in triplicate in 12-well plates at a density of
50,000 cells/well. After 24 h of culture, cells were treated with
DMSO (vehicle) or various concentrations of carnosol for the
indicated time period. Cell viability was measured with the Muse
Cell Analyzer (Millipore, Hayward, CA, USA) using the Muse
Count and Viability Kit (Millipore, Hayward, CA, USA) which
differentially stains viable and dead cells based on their
permeability to two DNA binding dyes. Data were presented as
proportional viability (%) by comparing the treated group with the
untreated cells, the viability of which is assumed to be 100%.
Cell cycle analysis
The cell cycle distribution analysis in DMSO- or carnosol-
treated MDA-MB-231 cells was performed with the Muse Cell
Analyzer (Millipore, Hayward, CA, USA) using the Muse cell
cycle kit (Millipore, Hayward, CA, USA) according to the
manufacturer’s instructions. Briefly, cells grown onto 6 cm culture
dish were treated with DMSO (vehicle) or various concentrations
of carnosol. After 24 h of treatment, cells were collected by
trypsinization, washed in PBS and resuspended in complete media
and the Muse cell cycle test reagent was then added to each test
tube. Cells were then incubated for 30 min at room temperature
in the dark. After staining, the cells were processed for cell cycle
analysis. Percentage of cells in G0/G1, S and G2/M phases were
determined using the FlowJo software.
Quantification of apoptosis by Annexin V labeling
The apoptosis was examined using the Annexin V & Dead Cell
kit (Millipore, Hayward, CA, USA) according to the manufactur-
er’s instructions. Briefly, MDA-MB-231 cells were treated with
DMSO (vehicle) or various concentrations of carnosol for 24 h.
Detached and adherent cells were collected and incubated with
Annexin V and 7-AAD, a dead cell marker, for 20 min at room
temperature in dark. The events for live, dead early and late
apoptotic cells were counted with the Muse Cell Analyzer
(Millipore, Hayward, CA, USA).
Quantification of multicaspase activity
Multicaspase activity was quantified by using the Muse
MultiCaspase assay kit (Millipore, Hayward, CA, USA). MDA-
MB-231 cells were seeded at a density of 50,000 cells/well into 12-
well plate in triplicate and treated with increasing concentrations
of carnosol in presence or absence of Tiron, a ROS scavenger, for
24 h, and multicaspase activity was assessed according to the
manufacturer’s instructions, using the Muse Cell Analyzer
(Millipore, Hayward, CA, USA).
Determination of intracellular reactive oxygen species
(ROS) production
Following treatment with the indicated concentrations of
carnosol for the specified time periods, cells were washed with
PBS and stained with 5 mM 29,79–dichlorofluorescein diacetate
(DCFDA) for 30 min at 37uC in the dark. ROS production was
determined by analysing fluorescently labelled cells using Nikon Ti
U fluorescence microscope.
Detection of autophagic vacuoles
MDA-MB-231 cells (56104) were grown in 12 well plates
followed by treatment with DMSO (vehicle) or indicated
concentrations of carnosol for 24 h. Following treatment cells
were washed and stained for autophagic vacuoles using the
autophagy detection kit (Abcam, Cambridge, UK) according to
the manufacturer’s instructions. Fluorescent autophagic vacuoles
were examined under Nikon Ti U fluorescence microscope.
Analysis of the mitochondrial membrane potential
The mitochondrial membrane potential changes were deter-
mined with the Muse Cell Analyzer (Millipore) using the Muse
MitoPotential kit (Millipore) according to the manufacturer’s
instructions. Briefly, cells grown in 12-well plates were treated with
DMSO (vehicle) or indicated concentrations of Carnosol for 24 h,
were collected by trypsinization, washed and incubated with the
Muse Mitopotential Dye, a cationic lipophilic dye, for 20 min in a
37uC CO2 incubator. Cells were then incubated with 7-AAD, a
dead cell marker, for an additional 5 min at room temperature.
Transmission electron microscopy
Control and carnosol-treated cells were fixed overnight at 4uC
in 2% paraformaldehyde, 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer pH 7.2 overnight at 4uC, before being post-fixed
with 1% OsO4 for 1 h. Cells were then dehydrated in a graded
ethanol series and embedded in Agar 100 epoxy resin. Ultrathin
sections were mounted on Cu grids and stained first with uranyl
acetate followed by lead citrate. Sections were observed and
photographed under a Philips CM10 Transmission Electron
Microscope.
Colony formation assay in soft agar
Assays were performed in six-well plates as previously described
[20]. The lower (base) layer consisted of 1 ml 2.4% Noble agar.
The base layer was overlaid with a second layer consisted of 2.9 ml
growth medium, 0.3% Noble agar, and 36104 MDA-MB-231
cells. Growth medium was then added and plates incubated at
37uC. Cells were allowed to grow to form colonies for 14 days
before carnosol was added. After 2 weeks, colonies were treated
with medium containing 25 mM carnosol for one more week.
Following treatment, plates were washed twice with PBS and then
colonies were fixed with 10% ice-cold methanol for 10 min and
washed once with PBS. Colonies were allowed to stain for 1 h in
solution containing 2% Giemsa. The size of the colonies were
measured, counted using a microscope (10X) and the colony size
was categorized as Large (.200 mM) or small (50–200 mM).
Colony sizes were expressed as a percentage of total counted
colonies and then compared to the vehicle treated controls
(ethanol). The experiment was repeated two times.
Whole Cell extract and Western Blotting analysis
Cells (1.86106) were seeded in 100 mm culture dishes and
cultured for 24 h before addition of Carnosol at the indicated
concentrations. After incubation, cells were washed twice with ice-
cold PBS, scraped, pelleted and lysed in RIPA buffer (Pierce)
supplemented with protease inhibitor cocktail (Roche) and
phosphatase inhibitor (Roche). After incubation for 30 min on
ice, cell lysates were centrifuged at 14,000 rpm for 20 min at 4uC.
Protein concentration of lysates was determined by BCA protein
assay kit (Thermo Scientific) and the lysates were adjusted with
lysis buffer. Aliquots of 25 mg of total cell lysate were resolved onto
8–15% SDS-PAGE. Proteins were transferred to nitrocellulose
membranes (Thermo Scientific) and blocked for 1 h at room
temperature with 5% non-fat dry milk in TBST (TBS and 0.05%
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Tween 20). Incubation with specific primary antibodies was
performed in blocking buffer overnight at 4uC. Horseradish
peroxidase-conjugated anti-IgG was used as secondary antibody.
Immunoreactive bands were detected by ECL chemiluminescent
substrate (Thermo Scientific). Where needed, membranes were
stripped in Restore western blot stripping buffer (Thermo
Scientific) according to the manufacturer’s instructions.
Knockdown of Beclin-1
MDA-MD-231 cells (250,000) were seeded in 6 cm cell culture
dish in serum-containing growth media and allowed to grow. After
24 hr, cells were transfected with SignalSilence Beclin-1 siRNA I
(100 nM) using DharmaFECT4 transfection reagent as described
by the manufacturer (Thermo Scientific). Cells were transfected
for 72 hr at 37uC in 5% CO2 before treating cells with and
without 50 mM carnosol in fresh complete media.
Statistical analysis
Results were expressed as means 6 S.E.M. of the number of
experiments. A Student’s t-test for paired or unpaired values was
performed and a p value of ,0.05 was considered statistically
significant.
Results
Carnosol inhibits the viability of the MDA-MB-231 breast
cancer cells
To examine the anticancer activity of carnosol on breast cancer
cells, we first measured the effect of increasing concentrations of
carnosol (0, 25, 50 and 100 mM) on the proliferation of the MDA-
MB-231 breast cancer cell line (Figure 1). Our results show that
the exposure of the MDA-MB-231 to carnosol decreased cellular
viability in a concentration- and a time-dependent manner. The
IC50 (producing half-maximal inhibition) was approximately
83 mM at 24 h and 25 mM at 48 h of treatment.
Carnosol induces G2-phase cell cycle block in MDA-MB-
231 cells
The ability of an anticancer drug to affect cell cycle distribution
can provide information regarding its cytotoxic mechanism(s) of
action. Moreover, carnosol has been shown to induce G2 block in
human prostate cancer PC3 cells [17]. For this reason, we
investigated the effect of carnosol on cell cycle distribution in
breast cancer cells. MDA-MB 231 cells were treated with
indicated concentrations of carnosol for 24 h and subjected to
cell cycle analysis. A concentration of 50 and 100 mM of carnosol
caused an obvious G/2M arrest on these cells (figure 2A and 2B).
Indeed, the population of G2/M increased significantly from 27 in
control to 47% and 36% in cell treated with 50 and 100 mM
carnosol, respectively, indicating that carnosol-treated MDA-MB-
231 cells were arrested in G2/M phase. No obvious change in the
cell cycle progression was observed at concentration of 25 mM
carnosol after 24 h treatment.
To determine whether carnosol induced cell cycle arrest
specifically at mitosis or G2 phase, we examined the phosphor-
ylation status of histone H3 (Ser 10). Histone H3 is phosphorylated
at serine 10 during mitosis by aurora kinase and the phosphor-
ylation status of H3 is considered a marker of mitosis [21].
Therefore, we investigated the expression of p(ser10)H3 and found
that carnosol treatment did not affect the phosphorylation level of
histone H3 in MDA-MB231 cells (Figure 2C). We have also
examined the expression of cyclin B1, in carnosol-treated cells.
Figure 1. Inhibition of cell viability by carnosol. Exponentially growing MDA-MB-231 were treated with vehicle (DMSO) and the indicated
concentrations of carnosol for 24 h and 48 h. Viable cells were assayed with the Muse Cell Analyzer as described by the manufacturer. Data represent
the mean 6SEM of at least 3 independent experiments. Student’s t test was performed to determine the significance (*p,0.05, **p,0.01 and ***p,
0.005).
doi:10.1371/journal.pone.0109630.g001
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Accumulation of cyclin B1 is well known to play an important role
in G2/M transition ant its upregulation invokes mitotic arrest. We
found that the level of cyclin B1 remained unchanged in response
to carnosol treatment (Figure 2D). Altogether these data confirm a
G2 arrest by carnosol in MDA-MB-231 breast cancer cells.
Next, we examined the expression level of the CDK inhibitor,
p21 in response to carnosol by Western blotting. The results of a
typical experiment shown in figure 2D, demonstrates a significant
and dramatic increase of p21 protein only when MDA-MB-231
cells were treated with concentrations (50 and 100 mM) causing
cell cycle arrest. No change in p21 protein level was observed with
25 mM carnosol, a concentration that did not affect cell cycle
progression. The level of another CDK inhibitor, p27 was also
determined in carnosol-treated cells. As it is shown in figure 2D,
the level of p27 showed a dose-dependent decrease in MDA-MB-
231 cells. Intriguingly, the decrease, although modest, in p27 level
was also observed at concentration of 25 mM carnosol. Taken
together, our results showed that carnosol-induced cell cycle arrest
at G2 phase correlates with p21 overexpression.
Carnosol induces apoptosis through the intrinsic and
extrinsic apoptotic pathways
Next, we investigated whether the observed growth inhibition
upon carnosol treatment was associated with induction of
apoptosis. Following 24 hours of treatment, annexin V staining
was detected in cells treated with 50 and 100 mM of carnosol
(Figure 3A), indicating that these cells are undergoing apoptosis.
No necrotic cells were detected at both concentrations. No
Annexin V stain was detected at lower concentration (25 mM),
indicating absence of apoptosis which is in agreement with the cell
viability data. In order to determine the apoptotic pathway
induced by carnosol in MDA-MB-231 cells, activation of caspase
3, 8 and 9 along with PARP cleavage was assessed by Western
blotting. As it is shown in figure 3B, cleaved PARP and cleaved
caspase 3, 8 and 9 increased in concentration-dependent (50 and
100 mM) manner in carnosol-treated cells. Again, neither caspase
activation nor PARP cleavage was detected in cells treated with
25 mM carnosol for 24 h. It appears then, that carnosol induces
cell death in MDA-MB-231 cells through the activation of the
Figure 2. Carnosol induces G2 arrest in MDA-MB-231 cells. (A–B) Cell cycle distribution analysis of carnosol-induced G2 cell-cycle arrest. MDA-
MB 231 cells were treated with carnosol at the indicated concentrations for 24 h, then analyzed with Muse Cell Analyzer using the Muse cell cycle kit
as described in Materials and Methods. (C–D) Effect of Carnosol on cell cycle markers. Cells were treated with DMSO or indicated concentrations of
carnosol and the expression level of histone H3-p(ser10), Cyclin B1, p21 and p27 was examined by western blotting after 24 post-treatment.
doi:10.1371/journal.pone.0109630.g002
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intrinsic and extrinsic pathways of apoptosis by the activation of
both caspase 8 and 9.
Carnosol modulates the expression of Bcl2/Bax proteins
and induces mitochondrial membrane potential
depolarization in MDA-MB-231 cells
Bcl2 family of proteins which includes Bcl2, and bcl-2 related
members such as Bax, plays a crucial role in regulation apoptosis.
Therefore, we decided to test the effect of carnosol on the
expression level of the anti-apoptotic Bcl2, and pro-apoptotic Bax,
proteins. As it is shown in figure 3B (lower panel), carnosol
reduced, in dose dependent manner, the level of Bcl2 while
increased the level of Bax in MDA-MB-231 cells leading to an
increase in the Bax/Bcl2 ratio which is in favor for apoptosis
induction.
Mitochondria are known to play a central role to elicit apoptosis
in response to many stresses and the loss of mitochondrial
membrane potential represents a hallmark for an early event in
apoptosis induction. In order to assess for the function of the
mitochondria and investigate whether mitochondria are involved
in carnosol-induced apoptosis, a change of the mitochondrial
membrane potential was analyzed as described in Material and
Methods. Results in figure 3C showed a concentration-dependent
increase in the number of cells with depolarized mitochondrial
membranes, thus suggesting that carnosol causes depolarization of
mitochondrial potential which could be linked with the activation
of apoptosis in MDA-MB-231 cells.
Carnosol induces Beclin1-independent autophagy in
MDA-MB-231 breast cancer cells
Light microscopy observation of MDA-MB-231 cells treated
with carnosol revealed cytoplasmic vacuolation (Figure 4A) that
might indicate that carnosol-induced cell death may be associated
with autophagy. In order to determine whether carnosol induces
autophagy, we examined by transmission electron microscopy, the
ultrastructure of MDA-MB-231 cells treated for 24 h with and
Figure 3. Induction of caspases-mediated apoptosis by carnosol in the MDA-MB-231 cells. (A) Carnosol induced apoptosis in the MDA-
MB-231 cells. Annexin V binding was carried out using Annexin V & Dead Cell kit (Millipore). Cells were treated with DMSO or various concentration of
carnosol for 24 h. Detached and adherent cells were collected and stained with Annexin V and 7-AAD and then the events for early and late apoptotic
cells were counted with the Muse Cell Analyzer as described in Materials and Methods. (B) Western blot analysis of caspase 3, -9, and -8 activation,
PARP cleavage and Bcl1 and Bax expression in MDA-MB-231 cells were treated with increasing concentrations of carnosol (25, 50 and 100 mM) for
24 h. (C) Carnosol induces the depolarization of mitochondrial membrane. Mitochondrial membrane potential (MMP) was assessed with the Muse
Cell Analyzer using the Muse MitoPotential kit as described in Materials and Methods. Data represent the mean 6SEM of at least 3 independent
experiments. Student’s t test was performed to determine the significance (*p,0.05, **p,0.01 and ***p,0.005).
doi:10.1371/journal.pone.0109630.g003
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without increasing concentrations (25, 50 and 100 mM) of
carnosol. As it appears in figure 4B (panel a), control MDA-MB-
231 cells showed an intact nuclei (N) and well developed organelles
such as endoplasmic reticulum, Golgi and numerous mitochon-
dria. In cells treated with low concentration of carnosol 25 mM, a
clearly visible double-membrane surrounded autophagosomes of
different sizes engulfing many cellular organelles, including
mitochondria can be seen (panel b, arrowhead). Swollen
mitochondria were observed as well (data not shown). Very little
cytoplasmic vacuoles were found and no obvious sign of cell death
was observed at this concentration. At higher concentration of
carnosol (50 and 100 mM) the presence of swollen and damaged
mitochondria exhibiting disorderly cristae structure (dashed
arrow), and very little intact mitochondria could be seen in all
cellular sections analyzed. Autophagolysosomes resulting from the
fusion of mitochondria and lysosomes were also observed (plain
arrow). Such fusion results in the formation of an increasing
number of empty vacuoles which then fuses (asterix) to form very
large number of macro-vacuoles that occupy most of the
cytoplasmic space. These observations suggest that carnosol
mediate its effect, at least in part, through induction of mitophagy.
Interestingly, very little organelles were present probably due to
massive degradation through autophagolysosome. Interestingly,
peripheral chromatin condensation and damaged nuclear enve-
lope (large arrow), two characteristics of apoptosis, were also
obvious in cells undergoing autophagy which indicates that the
two events, apoptosis and autophagy, co-exist in carnosol-treated
breast cancer cells.
To further confirm the formation of autophagic vacuoles in
carnosol-treated cells, we have used a fluorescence marker of
autophagy vacuoles as described in Material and Methods. As it is
shown, in figure 5A, exposure of MDA-MB-231 cells for 24 h to
carnosol led to a concentration-dependent accumulation of
autophagic vacuoles, thus further confirming the electron micros-
copy data. Autophagy is also characterized by the conversion of
LC3I (cytosolic form) into a lipidized LC3II (autophagosome
membrane-bound form). In order to further confirm autophagy in
carnosol-treated MDA-MB-231cells, LC3II accumulation was
analyzed by Western blotting in MDA-MB-231 treated with 25,
50 and 100 mM carnosol. As it is shown in figure 5B, carnosol
induced a concentration-dependent accumulation of the LC3-II.
Interestingly, autophagy is also detected in cells treated with
25 mM carnosol, a concentration that does not induce apoptosis.
The expression of another widely used autophagy-specific marker
p62(SQSTM1), a ubiquitin-binding protein involved in autophagy
and whose level decreases when autophagy flux increases, was also
evaluated. As shown in figure 5B, while the concentration of
25 mM show a slight increase in p62 (SQSTM1) expression, a
higher concentration of carnosol (50 and 100 mM) leading to
massive autophagy, showed a concentration-dependent decrease
in p62(SQSTM1). Although, it is widely known from the literature
that p62 gets degraded during the process of autophagy and that
an increase in p62 is related to cells becoming resistant to
autophagy. However, there are also reports showing that an
increase in p62 expression is required for autophagy induction
[22,41–43]. Hence, the conversion of LC3I/II along with the
modulation of p62 (SQSTM1) level confirm the formation of
autophagosome in carnosol-treated MDA-MB-231 cells. Next we
assessed the expression of Beclin1, an important autophagy
effector that plays a key role in autophagosome formation.
Western blotting data showed that the level of Beclin1 remained
unchanged in response to carnosol, thus suggesting that carnosol
induces autophagy that is Beclin1-independent (Figure 5B). To
confirm that Beclin-1 is not required for carnosol-induced
autophagy, we knocked out beclin-1 protein in MDA-MB-231
cells using Beclin-1-specific siRNA. As it is shown in figure 5C, we
Figure 4. Light and electron microscopy analysis of carnosol-treated MDA-MB-231 cells. (A) Micrograph of MDA-MB-231 cells, after 6 h
incubation with various concentrations of carnosol. (B) Representative electron micrographs of untreated MDA-MB-231 cells (a) and MDA-MB-231
cells treated with 25 (b), 50 (c) and 100 (d) mM carnosol for 24 h.
doi:10.1371/journal.pone.0109630.g004
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found that knock down of Beclin-1 did not inhibit LC3II
accucmulation and hence autophagy induced by carnosol. Taken
together, these data provide strong evidence that exposure of
MDA-MB-231 cells to carnosol triggers Beclin-1 independent
autophagy.
Recently, Wong and collaborators showed that ROS-dependent
ERK activation is for both apoptosis and beclin1-independent
autophagy in many cancer cell lines including the breast cancer
MDA-MB-231 cells [22]. This prompted us to measure, by
western blotting, the level of activation of ERK1/2 in carnosol-
treated MDA-MB-231 cells. Figure 5B, shows a clear dose-
dependent increase in pERK1/2 suggesting a possible involve-
ment of ERK activation in carnosol-mediated apoptosis and/or
autophagy.
Autophagy precedes apoptosis in carnosol-treated MDA-
MB-231 cells
A lot of studies reported that apoptosis and autophagy can be
both activated by anticancer drugs [23,24]. Our data showed that
both apoptosis and autophagy increased in concentration-depen-
dent manner in MDA-MB-231 cells in response to carnosol
treatment. In fact we found that while both apoptosis and
autophagy were found to coexist in MDA-MB-231 cells treated
Figure 5. Carnosol induces Autophagy in MDA-B231 cells. (A) Carnosol induces the formation of autophagic vacuoles MDA-MB 231 cells
observed after 24 h post treatment. MDA-MB-231 cells were seeded at a density of 56104 cells per well into 12-well plate followed by treatment with
DMSO (vehicle) or 50 and 100 mM carnosol. Following treatment cells were washed and stained for autophagic vacuoles using the autophagy
detection kit according to manufacturer’s instructions. Fluorescent autophagic vacuoles were examined under Nikon Ti U fluorescence microscope.
(B) Western blotting analysis of LC3II, p62(SQSTM1), Beclin-1 and pERK1/2 in carnosol-treated MD-MB 231 cells. Cells were treated with DMSO or
increasing concentration of carnosol for 24 h, then whole cell proteins were extracted and subjected to Western blot analysis, as described in
Materials and Methods, for LC3II, 62(SQSTM1), Beclin1, pERK1/2 and b-actin (loading control) proteins. (C) carnosol induced autophagy is
independent of Beclin1. MDA-MB-231 cells were transiently transfected with siRNA against Beclin1 for 72 hours followed by exposure to carnosol
(50 mM) for 24 hours. Whole cell lysates were then probed for LC3II. (D) Time-course analysis, by Western blotting, of PARP cleavage and LC3II
accumulation in carnosol-treated MDA-MB-231 cells. Cells were treated with 100 mM carnosol and proteins were extracted at the indicated time-point
(3, 6, 24 and 48 h) as described in Materials and Methods.
doi:10.1371/journal.pone.0109630.g005
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with high concentration of carnosol (50 and 100 mM); a lower and
non-cytotoxic concentration (25 mM) however, showed only sign
of autophagy but no caspase activation nor PARP cleavage was
detected. Cell death occurred, at this concentration, only after
48 h post-treatment. Based on these observations, it appears then,
that upon exposure to carnosol MDA-MB-231, cells first under-
goes autophagy and later, due to longer exposure and/or excessive
cellular damage, cells progress to apoptosis. In order to confirm
this, we have monitored the induction of autophagy and apoptosis
over time by performing time-course analysis of these two events.
MDA-MB-231 cells were treated for 24 h with 100 mM and
apoptosis was detected through PARP cleavage which is down-
stream of caspase activation, and autophagy through the
conversion of conversion of LC3I into LC3II. Figure 5D showed
that autophagy was triggered, although modestly, starting 3 h but
become more evident 6 h post-treatment. On the other hand,
PARP cleavage (Cl-PARP) occurred only 24 h post-treatment.
Our data clearly indicates that autophagy preceded apoptosis in
carnosol-treated MDA-MB-231 breast cancer cells.
Carnosol triggers ROS production and induces activation
of cH2AX, a marker of double strand breaks, in MDA-MB
231 cells
There are increasing evidences pointing out the involvement of
reactive oxygen species (ROS) in the induction of autophagy as
well as apoptosis [25,26]. Therefore we decided to examine the
effect of carnosol on ROS production in MDA-MB-231 cells.
Toward this, control and treated cells with increasing concentra-
tions of carnosol for 24 h were incubated with 29,79–dichloro-
fluorescein diacetate (DCFDA) and the ROS production was
observed under fluorescence microscopy. As it is shown in
figure 6A, microscopic observation of carnosol-treated cells
showed a significant dose-dependent increase in the intensity of
DCF-mediated fluorescence compared with control cells. In order
to assess whether ROS production is an early event that leads to
autophagy and/or apoptosis, a time-course measurement of ROS
production in MDA-MB-231 cells treated with 100 mM carnosol
was carried out. Figure 6B shows a significant accumulation of
ROS in time-dependent manner that was detected at 3 h post-
treatment, which also coincides with the time of LC3II accumu-
lation (Figure 5D). Still, a modest ROS production could be
detected as early as 1 h post-treatment. Our data suggests that
ROS production might be an early event that possibly triggers or
at least contribute in the induction of both autophagy and
apoptosis.
Several anticancer drugs were shown to induce apoptosis
through DNA damage. Genotoxic DNA damaging agents may
activate both membrane death receptors and the endogenous
mitochondrial damage pathway leading to cell death via apoptosis
[27]. Also, increasing evidences argue in favor of a role of DNA
damage in the induction of autophagy; however, the mechanism
through which DNA damage triggers autophagy and the role that
autophagy plays in the DNA damage response and cellular fate
remain unclear. Therefore, we sought, in the first instance, to
investigate whether carnosol induced DNA damage in MDA-MB-
231 cells. For this purpose, MDA-MB 231 cells were cultured for
24 h in absence or presence of 25, 50 or 100 mM carnosol and
DNA damage was determined by measuring the levels of
phosphorylated H2AX (cH2AX). Western blotting analysis
revealed a concentration-dependent increase in the levels of
cH2AX in response to carnosol treatment (Figure 6C), indicating
an accumulation of double strand breaks in these cells. A time-
course determination of DNA damage induced by 100 mM
carnosol revealed that the activation of cH2AX occurred as early
as 3 h post-treatment (Figure 6D), a time in which no cell death
(data not shown) nor apoptosis were observed, thus ruling out the
possibility that the induction of DNA damage is a consequence of
DNA fragmentation resulting from caspase activation. From these
results, it appears that the induction of apoptosis and/or
autophagy correlates with the amount of DNA damage detected,
which is dependent on the concentration of carnosol used in the
treatment. Autophagy was detected when low amount of DNA
damage occurred in the cell, while apoptosis was detected in cells
showing excessive DNA damage. These data suggests that DNA
damage could account, at least in part, in the induction of both
apoptosis and autophagy in carnosol-treated breast cancer cells.
The ROS scavenger tiron attenuates DNA damage,
autophagy and apoptosis in carnosol-treated cells
Although ROS is known to induce autophagy and apoptosis,
evidence that autophagy also triggers ROS exists [28]. Our data
showed that the accumulation of ROS become evident as early as
1 h post-treatment with carnosol (figure 6B), while autophagy,
examined through LC3II accumulation, started after 3 h (Fig-
ure 5D) suggesting that ROS generation is upstream of autophagy
induction. In order to examine the role of ROS generation in
autophagy and apoptosis induction, we examined the effect of
tiron, a ROS scavenger, on cell viability, caspases activation,
PARP cleavage and LC3II accumulation. Light microscopy
observation revealed that cells pre-treated with tiron for 1 h prior
to treatment with 50 mM carnosol were indistinguishable from the
control cells as no sign of vacuolation, nor apoptotic cells were
observed (figure 7A). Similarly the effect of 100 mM carnosol was
also attenuated by tiron as much less apoptotic cells could be
observed and only few cells showed vacuolation (figure 7A). Next,
MDA-MB-231 cells were treated with 50 or 100 mM carnosol with
and without tiron and cell viability was determined as described in
Material and Methods. As it is shown in figure 7B, inhibition of
ROS generation completely reversed the effect of 50 mM carnosol
on cell viability. Our data showed that a concentration of 50 mM
of carnosol has no effect on cell viability when cells were pre-
treated with tiron. Similarly, tiron dramatically reduced the effect
of 100 mM carnosol. Cell survival shifted from 50% with carnosol
alone, to 80% when tiron was present. To assess for apoptosis, we
first treated MDA-MB-231 cells with 50 and 100 mM with and
without tiron and measured total caspases activity in the cells.
Figure 7C, showed that, in absence of tiron, 50 and 100 mM
carnosol led to a concentration-dependent activation of total
cellular multicaspases. However, when tiron was present, 50 mM
carnosol showed no changes in multicaspase activity pattern
compared with control. Absence of caspases activation was also
confirmed by the absence of PARP cleavage (figure 7C) indicating
absence of cell death in these cells (Figure 7D). Similarly, Tiron
also reduced the effect of 100 mM carnosol on apoptosis induction
revealed by less cellular multicaspase activation (Figure 7C) and
reduced PARP cleavage (Figure 7D) compared to cells treated
with carnosol alone. Taken together, these data strongly argue in
favor of ROS-dependent induction of apoptosis in MDA-MB-231
cells.
A link between ROS production and autophagy induction was
also investigated. We found that attenuation of ROS level by tiron
significantly decreased the level of LC3II, a hallmark for
autophagy induction. Western blot analysis revealed that the level
of LC3II accumulation observed in cells treated with 50 mM in
presence of tiron was comparable to that of control (Figure 7D),
indicating the absence of autophagy in these cells, in agreement
with light microscopy observation which showed no vacuolation.
On the other hand, a concentration of 100 mM, did not suppress
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but only attenuated autophagy, again in agreement with light
microscopy observation which revealed vacuolation. Reduction of
apoptosis but not of autophagy by tiron at a concentration of
100 mM carnosol could be explained by the fact that the quantity
of ROS induced by this concentration of carnosol exceeds the
scavenging capacity of tiron. As result, we believe that tiron
reduces the intracellular concentration of ROS to a level enough
to trigger autophagy but below a threshold required for activation
of massive apoptosis. These data strongly suggest that the
intracellular concentration of ROS determines the response of
breast cancer cells toward either autophagy only or autophagy and
apoptosis.
Excess ROS production was shown to cause various cellular
damages including DNA damage. Conversely, DNA damage
resulting from different sources was also shown to increase ROS
levels, which in turn contribute to the induction of cell death.
Because we found that increasing intracellular ROS generation
correlated with the activation of the marker of DNA damage,
cH2AX (Figure 6C and 6D), we wanted to determine which of the
two events, ROS production or DNA damage, occurred first in
carnosol-treated breast cancer cells. As it is shown in figure 7E,
inhibition of ROS production by tiron, attenuated the activation
of cH2AX and hence DNA damage in MDA-MB-231 cells,
indicating that DNA damage occurred downstream of ROS
production. Collectively, these results demonstrate that carnosol
exerts its anti-breast cancer effect through a ROS-dependent
mechanism(s) that includes DNA damage, and that inhibition of
ROS generation is enough to block both carnosol-induced
autophagy and apoptosis.
Carnosol Inhibits Colony Growth of MDA-MB-231
To further confirm the inhibitory potential of carnosol on
MDA-MB 231 cells, we sought to determine if carnosol could
inhibit the further growth of already formed MDA-MB-231
colonies. For this purpose, MDA-MB-231 cells were first allowed
to grow and form visible colonies in absence of treatment. After 14
days of growth, colonies were incubated with DMSO as control or
25 mM carnosol and allowed to grow for one more week. Figures 8
shows that the size of the DMSO-treated (control) colonies kept
growing compared to the size of the two weeks colonies; more
large colonies were obtained in the three weeks plate, while less
small colonies were counted, indicating that small colonies became
larger in size. On the other hand, carnosol-treated colonies shows
regression in colony size compared to the two weeks colonies. In
fact, in the carnosol-treated plates, the number of large size
colonies counted at three weeks (17.3%) was less than what was
obtained in the two weeks plate (38.75%), while the number of
small colonies was significantly greater going from 61.25% at two
Figure 6. ROS generation and DNA damage accumulation in carnosol-treated MDA-MB-231 cells. (A) Carnosol induces ROS generation
in MDA-MB-231 cells. Cells were treated with indicated concentrations of carnosol for 24 h and ROS production was analyzed, as described in Material
and Methods, using DCFDA fluorescence stain. (B) time-course measurement of ROS generation in carnosol-treated MDA-MB-231 cells. Cells were
treated with 100 mM carnosol and ROS generation was examined at different time-point (1, 3 and 6 h). (C–D) Concentration and time-dependent
accumulation of cH2AX, marker of DNA damage, in carnosol-treated cells. DNA damage was evaluated by measuring, by Western blotting, the level
cH2AX accumulation using anti-phospho-H2AX (ser 139) antibody.
doi:10.1371/journal.pone.0109630.g006
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weeks to 82.75% at three weeks, suggesting size regression in the
large colony in response to carnosol treatment. This result along
with the viability and cell cycle data confirm the anti-cancer effect
of carnosol on the MDA-MB-231 breast cancer cells.
Discussion
The triple negative breast cancer (TNBC) is considered as
highly aggressive form of cancer with poor survival rate for the
patients [29]. Currently, treatment of TNBC is mainly through
conventional chemotherapy which showed limited long-term
success [30]. Hence, Identification of new more effective
therapeutic compounds against TNBC remains an important
clinical challenge.
In the present study we investigated the effectiveness of
carnosol, a natural compound, against the TNBC MDA-MB-
231 cells. We showed that carnosol efficiently inhibited in vitro
and in vivo the growth of the MDA-MB-231 cells. We found that
carnosol induced cell cycle arrest at G2 phase confirmed by a
decrease in p(ser10) histone H3 . G2 arrest by carnosol was also
shown in prostate cancer PC3 cells [17] and was associated with
an upregulation of the CDK inhibitors p21 and p27. In MDA-
MB-231 cells, however, we found that the cell cycle arrest
correlated with an upregulation of the CDK inhibitor p21 and
down regulation of p27, thus suggesting that carnosol-induced cell
cycle arrest in TNBC might involves different mechanism(s) and
does not require p27. Similar to carnosol, salinomycin, a
monocarboxylic polyether antibiotic, was also shown to induce
G2 arrest, upregulation of P21 and downregulation of p27 in
MDA-MB-231 cells [31]. We also found that arrested MDA-MB-
231 cells, in response to carnosol, undergoes apoptosis. This
finding is in agreement with previous reports demonstrating that
the anticancer effect of carnosol on leukemia [19], prostate cancer
[15,17] and colon cancer [18] cell lines was due to its apoptosis-
inducing activity. Interestingly, our results showed for the first time
that carnosol activated both intrinsic and extrinsic apoptotic
pathway in TNBC through an activation of caspase 9 and 8
respectively. Carnosol induced expression of pro-apoptotic protein
Figure 7. The ROS scavenger tiron attenuates carnosol-mediated autophagy, apoptosis and DNA damage in MDA-MB-231 cells. (A)
Micrograph observation of MDA-MB-231 cells pretreated with or without tiron for 1 h and then treated with 50 and 100 mM carnosol for 24 h. (B)
Cells pretreated with or without tiron for 1 h and then treated with 50 and 100 mM carnosol for 24 h. Cell viability was determined with the Muse Cell
Analyzer as described by the manufacturer. Cell viability assay was performed in triplicate and results obtained represent the average of three
independent experiments. (C) Multicaspase activity in MDA-MB-231 cells pretreated with carnosol for 1 h and then treated with 50 and 100 mM of
carnosol for 24 h. Multicaspase activity was analyzed using the Muse Multicaspase assay kit and quantified on the Muse Cell Analyzer. Total cellular
caspase activity assay was performed in triplicate and results obtained represent the average of three independent experiments. (D) Western blotting
analysis of LC3II accumulation, PARP cleavage and (E) cH2AX expression in MDA-MB-231 cells pretreated with or without tiron for 1 h and then
treated with 50 and 100 mM of carnosol for 24 h.
doi:10.1371/journal.pone.0109630.g007
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with concomitant decrease of Bcl2 expression and loss of
mitochondrial membrane potential.
Increasing number of anticancer therapies has been shown to
induce autophagy in different cancer cell types [32]. Still, whether
autophagy in response to anticancer therapies is pro-death or pro-
survival remains subject to debate. However, there are increasing
evidences that Beclin1-independent autophagy is invariably
associated with cell death [33,34]. In the present study, we found
that carnosol also induced autophagy in MDA-MB-231. This
finding is supported by large body of evidence, (i) Electron
micrograph observation of autophagy features such as massive
mitophagy and cytoplasmic vacuolation, (ii) modulation of
autophagy-specific markers such as conversion of LC3 I to LC3
II and modulation of p62(SQSTM1) accumulation. To our
knowledge this is the first study to show that carnosol induces
autophagy in cancer cell lines. We found that autophagy
induction, which occurred as early as 3 h post-treatment, precedes
the activation of the programmed cell death which took place at
24 h post-treatment. Moreover, electron micrograph analysis
revealed the existence of both events, i.e. autophagy and apoptosis,
within the same cell. Simultaneous induction of autophagy and
caspase-dependent apoptosis in cancer cells was also described for
several anticancer compounds such canabidiol in the breast cancer
MDA-MB-231 cells [36], microtubule-modulating agent, Red-Br-
nos [35] and oridonin [36] in PC3 prostate cancer cells. To our
knowledge, this is the first report that shows that carnosol induces
autophagy in cancer cells. Strikingly we found that carnosol-
induced autophagy is Beclin1-independent. In fact the level of
Beclin1 remained unchanged under all experimental conditions
used of concentrations or time of exposure (data not shown), hence
demonstrating that carnosol-mediated autophagy is beclin1-
independent in MDA-MB-231 cells. Although Beclin1 was most
of the time perceived as key player in autophagy execution and its
knock down blocks autophagic cell death [37], a recent study by
Wong and collaborators showed that small molecule compound,
referred as C1, that triggers intracellular ROS production,
induced simultaneous induction of Beclin1-independent autopha-
gy and apoptosis in various cancer cell type including MDA-MB-
231 breast cancer cells [21]. These authors also showed that
sustained ERK1/2 activation act as an upstream effector
controlling both autophagy and apoptosis in response to high
level of intracellular ROS, and that its pharmacological inhibition
blocked the C1 induced autophagy and apoptosis [21]. Interest-
ingly, here we showed that carnosol induced both ROS
Figure 8. Carnosol inhibits MDA-MB-231 colony growth. Carnosol induced arrest of MDA-MB-231 colony growth. MDA-MB-231 colonies were
first allowed to form in normal media for 2 weeks as described in Material and Methods. Formed colonies were then treated with DMSO or 25 mM
carnosol and allowed to grow for one more week before staining. Inhibition of colony growth was assessed by measuring the size of the colonies
obtained in DMSO and carnosol-treated plate. Data were compared with those obtained for the 2 weeks colonies. The size of the colonies were
measured, counted using a microscope (106) and the colony size was categorized as Large ($200 mM), or small (50–200 mM). Student’s t test was
performed to determine the significance (*p,0.05, **p,0.01 and ***p,0.005).
doi:10.1371/journal.pone.0109630.g008
Induction of Autophagy and Apoptosis by Carnosol
PLOS ONE | www.plosone.org 12 October 2014 | Volume 9 | Issue 10 | e109630
production and sustained ERK1/2 activation hence strongly
suggesting that carnosol might exerts its cytotoxic effect on TNBC
at least partly through ERK1/2 activation. This study adds
carnosol to the increasing list of anticancer compounds that induce
Beclin1 independent autophagy in tumor cells.
There is increasing number of evidences highlighting the central
role of ROS production in inducing autophagy and cell death in
many cancer cell types. In fact, several anticancer agents were
shown to mediate their effect through ROS, and inhibition of
ROS production by ROS scavenger blocks autophagy and cell
death in many cancer types [34, 35, 38, and 39]. Similarly, in this
study we observed carnosol-enhanced ROS generation in breast
cancer cells in dose- and time-dependent manner. Recent studies
showed that the extent of ROS level produced, in response to
anticancer agents, elicits different responses in cancer cells. While
low level of ROS was shown to induce autophagy, excessive ROS
accumulation triggered both apoptosis and cell death. In
agreement with these studies, we found that, depending on the
concentration and time of exposure, carnosol elicited different
responses in MDA-MB-231 cells. We found that carnosol at non
cytotoxic concentration (25 mM) resulted in low level in ROS
production and cH2AX activation, and induced autophagy. We
believe that in this context, autophagy was induced to remove
damaged organelles from treated cells. However, exposure of cells,
for short period of time, to higher concentration of carnosol ($
50 mM) triggered autophagy as self-defense survival mechanism. A
prolonged exposure to such concentration of carnosol led to
excessive ROS production, which ultimately resulted in higher
levels of oxidative damage that exceeds the cell’s repair capabilities
that eventually caused programmed cell death through activation
of intrinsic and extrinsic apoptotic pathways. These findings which
highlight the essential role of ROS accumulation are supported by
the following evidence: The abrogation of ROS production by the
ROS scavenger tiron, totally blocked autophagy and apoptosis in
cells treated with 50 mM carnosol and significantly attenuated both
events at a higher concentration (100 mM). Altogether, these data
strongly demonstrate that ROS production in response to carnosol
act as an upstream effector for autophagy and subsequent
apoptosis induction. Similar mechanism has been described by
Lin and collaborators for safingol, an anticancer drug in phase I
clinical trial, which has been shown to mediate a concentration-
dependent effect in MDA-MB-231 and HT29 cancer cells [38].
These authors showed that Low concentration of safingol triggered
autophagy as damage repair mechanism, while higher concentra-
tion led to cell death [38].
DNA damage caused by genotoxic chemicals or ROS
accumulation was shown to induce autophagy. Still the mecha-
nisms by which DNA damage triggers autophagy are unclear [40].
Interestingly, we found that carnosol induced a dose-dependent
increase in cH2AX, a marker of DNA damage, detected as early
as 3 h, a time that coincides with autophagy induction. Most
importantly, we found that inhibition of ROS production by tiron
attenuated the activation of cH2AX. Bases on these finding, we
demonstrate that DNA damage is a downstream response to ROS
production that might contribute to induce autophagy and
apoptosis in MDA-MB-231 cells.
Nowadays, much attention is directed toward the potential role
of mitochondria damage in autophagy induction. The current
hypothesis is that cells respond to mitochondrial damage in a
graded fashion: when only a few mitochondria are damaged,
autophagy takes place and the mitochondria are degraded; when
more mitochondria are damaged, apoptosis is induced, and the
cells die [32]. In agreement with this hypothesis, our electron
micrograph data clearly revealed that carnosol affected the
mitochondrial morphology in dose-dependent manner which
ultimately resulted in loss of mitochondrial membrane potential.
Thus, the induction of autophagy with or without subsequent
apoptosis activation might reflect the extent of mitochondria
damage in carnosol-treated cells.
In conclusion, our data are consistent with a model shown in
figure 9, in which treatment with carnosol triggers oxidative
damage to TNBC. The magnitude of damage, which depends
upon the concentration of carnosol, determines the response of the
cells. We propose that in the presence of large amounts of
intracellular damages induced by high concentration of carnosol,
MDA-MB-231 cells respond by triggering autophagy with
subsequent apoptosis through an activation of both intrinsic and
extrinsic pathway. In contrast, limited intracellular damage caused
by low concentration of carnosol triggers only autophagy as repair
mechanism. Our current study provides experimental evidence
Figure 9. Hypothetic model illustrating the differential effect of carnosol in MDA-MB-231 breast cancer cells.
doi:10.1371/journal.pone.0109630.g009
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that the plant-derived carnosol can be promising candidate for
triple negative breast cancer therapy.
In the present study, we investigated the effect of carnosol on
the highly proliferative and invasive triple-negative MDA-MB-231
human breast cancer cells. We show for that carnosol blocked cell
cycle at G2 phase and induced ROS-dependent apoptosis and
beciln1-independent autophagy in MDA-MB-231 breast cancer
cells.
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